7 results
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Diagnosis and Management ... pANCA anti-MPO - Negative ... life-threatening • Treatment ... : Chronic disease ... #Summary #rheumatology
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Erythematosus (SLE ... Cerebrovascular Disease ... APS), Secondary prevention ... CNS #neurology #rheumatology ... cerebritis #diagnosis #management
Hematuria in Post-Renal Transplant Patient
Prevalence up to 12% in the postrenal transplant patient
 • Bacterial: Escherichia
Virus • Fungal: Candida ... , Busulfan • Disease ... Goodpasture's syndrome, SLE ... #blood #urine #management ... #treatment #nephrology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
pANCA anti-MPO - Negative ... Usual therapeutic management ... : Chronic disease ... comparison #table #rheumatology ... #diagnosis #management
Management of Suspected and Confirmed Candida auris 

Isolate patients with suspected C auris 
 • Private
Management of Suspected ... and Confirmed Candida ... disinfection Begin treatment ... Control and Prevention ... #Diagnosis #InfectiousDiseases
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... for Preventing ... improvement and a negative ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... Severe Disseminated Disease ... #Prevention #Treatment ... #management #opportunistic